Patent Assignment
Reel/Frame 051741/0848
Assignment of Assignor's Interest
Recorded: 2020-02-06
Pages: 19
Assignor
CELGENE TRI A HOLDINGS LTD.
Executed: 2017-08-09
Assignee
CELGENE INTERNATIONAL II SARL
RUE DES NASIEUX 18, COUVET, CH-2108, SWITZERLAND
Covered Properties
(2)
Compositions and Methods for Treating Neoplastic Diseases
Compositions and Methods for Treating Neoplastic Diseases
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 17, 2012
From: PALLADINO, MICHAEL A.
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 028618/0850 →
Assignment of Assignor's Interest
Jul 17, 2012
From: PALLADINO, MICHAEL A.
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 028618/0860 →
Assignment of Assignor's Interest
Jun 24, 2013
From: NEREUS PHARMACEUTICALS, INC.
To: TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
Reel/Frame 030670/0412 →
Assignment of Assignor's Interest
Oct 10, 2013
From: ANDERSON, KENNETH C.; CHAUHAN, DHARMINDER
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 031384/0805 →
Assignment of Assignor's Interest
Feb 13, 2017
From: NEREUS PHARMACEUTICALS, INC.
To: TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
Reel/Frame 041698/0404 →
Assignment of Assignor's Interest
Jun 8, 2018
From: PALLADINO, MICHAEL A.
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 046029/0468 →
Assignment of Assignor's Interest
Jun 11, 2018
From: 1096271 B.C. UNLIMITED LIABILITY COMPANY
To: CELGENE TRI A HOLDINGS LTD.
Reel/Frame 046047/0177 →
Assignment of Assignor's Interest
Jun 11, 2018
From: CELGENE RESEARCH AND DEVELOPMENT I ULC, FORMERLY KNOWN AS TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
To: 1096271 B.C. UNLIMITED LIABILITY COMPANY
Reel/Frame 046047/0201 →
Assignment of Assignor's Interest
Feb 6, 2020
From: ANDERSON, KENNETH C.; CHAUHAN, DHARMINDER
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 051743/0203 →